{
    "eid": "2-s2.0-85151684565",
    "title": "Clinical trials for cognition in Parkinson's disease: Where are we and how can we do better?",
    "cover-date": "2023-07-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neurology",
            "@code": "2808",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Geriatrics and Gerontology",
            "@code": "2717",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Neurology (clinical)",
            "@code": "2728",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Clinical trials",
        "Cognitive impairment",
        "Parkinson's disease"
    ],
    "authors": [
        "Ece Bayram",
        "Lucia Batzu",
        "Bension Tilley",
        "Rhea Gandhi",
        "Priya Jagota",
        "Roberta Biundo",
        "Michela Garon",
        "Tittaya Prasertpan",
        "Claudia Lazcano-Ocampo",
        "K. Ray Chaudhuri",
        "Rimona S. Weil"
    ],
    "citedby-count": 1,
    "ref-count": 81,
    "ref-list": [
        "Parkinson's disease",
        "Risk of dementia in Parkinson's disease: a community-based, prospective study",
        "The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort",
        "Cognitive decline in Parkinson disease",
        "Cognitive impairment in Parkinson disease",
        "Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement Disorder Society Task Force guidelines",
        "Natural course of mild cognitive impairment in Parkinson disease",
        "Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease",
        "Rivastigmine for dementia associated with Parkinson's disease",
        "Pharmacological management of Lewy body dementia: a systematic review and meta-analysis",
        "Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis",
        "Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial",
        "Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial",
        "Memantine improves attention and episodic memory in Parkinson's disease dementia and dementia with Lewy bodies",
        "Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease",
        "Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer's disease: systematic review and meta-analysis",
        "Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: a pilot open-label study",
        "A randomized clinical trial of atomoxetine for mild cognitive impairment in Parkinson's disease",
        "The spectrum of cognitive impairment in Lewy body diseases",
        "Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies",
        "RoB 2: a revised tool for assessing risk of bias in randomised trials",
        "The GRADE system for rating clinical guidelines",
        "Allogeneic bone marrow\u2013derived mesenchymal stem cell safety in idiopathic Parkinson's disease",
        "Trial of prasinezumab in early-stage Parkinson's disease",
        "Safety and efficacy of mevidalen in Lewy body dementia: a Phase 2, randomized, placebo-controlled trial",
        "Safety of plasma infusions in Parkinson's disease",
        "\u03b14\u03b22 * nicotinic cholinergic receptor target engagement in Parkinson disease gait\u2013balance disorders",
        "Non\u2010motor symptoms in Parkinson's disease are reduced by nabilone",
        "Low-dose niacin supplementation improves motor function in US veterans with Parkinson's disease: a single-center, randomized, placebo-controlled trial",
        "Expectations of benefit in a trial of a candidate disease\u2010modifying treatment for Parkinson disease",
        "Immersive technology for cognitive-motor training in Parkinson's disease",
        "Goal management training and psychoeducation/mindfulness for treatment of executive dysfunction in Parkinson's disease: a feasibility pilot trial",
        "Art therapy for Parkinson's disease",
        "Computerized physical exercise improves the functional architecture of the brain in patients with Parkinson's Disease: a network science resting-state EEG study",
        "Can Qigong improve non-motor symptoms in people with Parkinson's disease - a pilot randomized controlled trial?",
        "Implementation of the HiBalance training program for Parkinson's disease in clinical settings: a feasibility study",
        "Physical activity profiles in Parkinson's disease",
        "Implementation of high\u2010cadence cycling for Parkinson's disease in the community setting: a pragmatic feasibility study",
        "Group-based music intervention in Parkinson's disease \u2013 findings from a mixed-methods study",
        "Effect of eight-week online cognitive training in Parkinson's disease: a double-blind, randomized, controlled trial",
        "Effects of computer-based cognitive rehabilitation on attention, executive functions, and quality of life in patients with Parkinson's disease: a randomized, controlled, single-blinded pilot study",
        "The effect of repetitive transcranial magnetic stimulation on cognitive impairment in Parkinson's disease with dementia: pilot study",
        "Caloric vestibular stimulation for the management of motor and non-motor symptoms in Parkinson's disease",
        "Clinical evaluation and resting state fMRI analysis of virtual reality based training in Parkinson's disease through a randomized controlled trial",
        "Cognitive effects of theta frequency bilateral subthalamic nucleus stimulation in Parkinson's disease: a pilot study",
        "Theta-burst stimulation for cognitive enhancement in Parkinson's disease with mild cognitive impairment: a randomized, double-blind, sham-controlled trial",
        "Short versus conventional pulse\u2010width deep brain stimulation in Parkinson's disease: a randomized crossover comparison",
        "Lateralized subthalamic stimulation for axial dysfunction in Parkinson's disease: a randomized trial",
        "Clinical trials for disease-modifying therapies in Alzheimer's disease: a primer, lessons learned, and a blueprint for the future",
        "Lecanemab in early Alzheimer's disease",
        "Donanemab in early Alzheimer's disease",
        "Does ethnicity influence recruitment into clinical trials of Parkinson's disease?",
        "Open science takes on Parkinson's disease",
        "Unmet needs of women living with Parkinson's disease: gaps and controversies",
        "Expanding sexual and gender minority research in movement disorders: more than awareness and acceptance",
        "Lost in translation: the valley of death across preclinical and clinical divide \u2013 identification of problems and overcoming obstacles",
        "Dementia: timely diagnosis and early intervention",
        "Early intervention in Alzheimer's disease: how early is early enough?",
        "Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study",
        "Prediction of cognition in Parkinson's disease with a clinical\u2013genetic score: a longitudinal analysis of nine cohorts",
        "Development and external validation of a prognostic model in newly diagnosed Parkinson disease",
        "Predictors of dementia in Parkinson disease: a prospective cohort study",
        "Visual dysfunction predicts cognitive impairment and white matter degeneration in Parkinson's disease",
        "Visual impairment is more common in Parkinson's disease and is a risk factor for poor Health outcomes",
        "Visual acuity and development of Parkinson's disease: a nationwide cohort study",
        "Cognitive rehabilitation in Parkinson's disease: is it feasible?",
        "Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials",
        "Long-term cognitive decline in dementia with Lewy bodies in a large multicenter, international cohort",
        "Great expectations: the placebo effect in Parkinson's disease",
        "The Hawthorne effect as a pre-placebo expectation in Parkinsons disease patients participating in a randomized placebo-controlled clinical study",
        "Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Hawthorne effects",
        "Spatiotemporal gait patterns during overt and covert evaluation in patients with Parkinson's disease and healthy subjects: is there a Hawthorne effect?",
        "Impact of Hawthorne effect on healthcare professionals: a systematic review",
        "The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment",
        "Mini-mental state",
        "MMSE and MoCA in Parkinson's disease and dementia with Lewy bodies: a multicenter 1-year follow-up study",
        "Responsiveness to change of the montreal cognitive assessment, mini-mental state examination, and SCOPA-cog in non-demented patients with Parkinson's disease",
        "Detecting mild cognitive deficits in Parkinson's disease: comparison of neuropsychological tests",
        "Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations",
        "An update on fluid biomarkers for neurodegenerative diseases: recent success and challenges ahead",
        "Can neuroimaging predict dementia in Parkinson's disease?"
    ],
    "affiliation": [
        {
            "affiliation-city": "Padua",
            "@id": "60000481",
            "affilname": "Universit\u00e0 degli Studi di Padova",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000481",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "London",
            "@id": "60022148",
            "affilname": "University College London",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022148",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "San Diego",
            "@id": "60121548",
            "affilname": "Department of Neurosciences",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60121548",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Puente Alto",
            "@id": "60025321",
            "affilname": "Hospital Dr. Sotero del Rio",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025321",
            "affiliation-country": "Chile"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "London",
            "@id": "60021923",
            "affilname": "King's College Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021923",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "London",
            "@id": "60015150",
            "affilname": "Imperial College London",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015150",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "London",
            "@id": "60011520",
            "affilname": "King's College London",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011520",
            "affiliation-country": "United Kingdom"
        }
    ],
    "funding": [
        "GE Healthcare and Britannia",
        "National Institutes of Health",
        "National Institute on Aging",
        "Wellcome Trust",
        "Italian Ministry of Health",
        "Horizon 2020"
    ]
}